Carenet Health buys AI consultancy Invene to deepen healthcare tech push
What's the deal? Carenet Health has acquired Invene, a healthcare-focused AI, data engineering and technology consulting firm. The deal, announced October 15, 2026, adds Invene's consulting and engineering teams to Carenet's healthcare engagement platform. Financial terms were not disclosed.
What each does: Founded in 2018, Invene advises health insurers, providers, value-based care companies and electronic health record vendors on AI strategy, workflow automation and data interoperability. Carenet runs an engagement platform combining patient and member technology, clinical services, data intelligence and operational support.
Why it matters: Invene reports work with 20 Fortune 100 companies and says its team has helped launch more than 400 products reaching over 1 billion users. It has also made the Inc. 5000 list of fast-growing private firms for two consecutive years.
What's the endgame? The acquisition lets Carenet offer services spanning technology strategy, development, implementation and ongoing support. "Healthcare companies want to put AI to work responsibly and profitably, with a partner who can orchestrate, build, and run it," said Christopher Rogers, president of Carenet Health.
Why now? Healthcare organisations are increasingly evaluating AI to automate administrative tasks and support patient interactions. But deploying these systems demands reliable data infrastructure and integration with existing clinical technology — the challenges Invene focuses on addressing.
The signal: The deal reflects a wider move to pair AI consulting muscle with clinical and operational execution, as healthcare firms look for single partners to build and run their technology rather than stitch together vendors.
Read more: citybiz.co
Image credit: Generated with Gemini
